Publication | Closed Access

Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer

Breast OncologyNeoadjuvant Endocrine TherapyHormonal ReceptorReceptor Tyrosine KinaseBreast CancerRadiation OncologyMedicineCell BiologyCell SignalingCancer ResearchEndocrine-related Cancer